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Background: This randomised, double-blind study was designed to assess the analgesic efficacy of dexmedetomidine as 
compared with fentanyl as an adjunct to local anaesthetic in thoracic epidural for upper abdominal surgeries.
Methods: Forty adult patients of American Society of Anesthesiologists grade I–II undergoing upper abdominal surgery 
were randomly allocated into two groups to receive 50 μg fentanyl or 50 μg dexmedetomidine as an adjunct to 10 ml 0.125% 
bupivacaine via thoracic epidural. Anaesthesia was induced with morphine, propofol and vecuronium and maintained by 
isoflurane with 60% nitrous oxide in oxygen. In the postoperative period patient-controlled analgesic pumps were used to deliver 
similar types of mixtures via the epidural catheter. Patients were evaluated for rescue analgesic requirements, haemodynamic 
stability, postoperative pain, sedation and any adverse events.
Results: The groups were comparable regarding intraoperative analgesic requirements, recovery times and postoperative pain 
scores. The total consumption of rescue analgesia was significantly less in the dexmedetomidine group as compared with the 
fentanyl group (p = 0.049). Two patients in the fentanyl group had vomiting and one had pruritus. None of the patients had 
bradycardia, hypotension, excessive sedation or respiratory depression. Patients receiving epidural dexmedetomidine were 
more satisfied with the technique than those receiving fentanyl (p < 0.001).
Conclusion: It was concluded that the addition of dexmedetomidine with 0.125% bupivacaine in thoracic epidural provides 
effective perioperative analgesia with greater patient satisfaction compared with fentanyl.
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Introduction 
Upper abdominal surgeries are usually associated with large 
surgical incisions and extensive gut handling and manipulation, 
which increases the need for intraoperative and postoperative 
analgesia. Uncontrolled postoperative pain and 
pathophysiological response to surgery make these patients 
prone to high stress, sympathetic activation and slow 
convalescence, and may cause significant complications of many 
organ systems.1
Thoracic epidural analgesia (TEA) provides good postoperative 
pain relief and facilitates deep-breathing exercises and early 
ambulation. TEA also decreases the sympathetic outflow, 
preventing ileus and the incidence of postoperative myocardial 
infarction by providing favourable redistribution of coronary 
blood flow, attenuating the stress response and 
hypercoagulability.2,3 Although adjuvants like fentanyl have a 
dose-sparing effect and provide superior analgesia after major 
upper abdominal surgeries,4 there is always the possibility of an 
increased incidence of pruritus, urinary retention, postoperative 
nausea and vomiting and respiratory depression with the use of 
opioids.5,6
Recently α2-agonists have shown promise as an adjuvant to local 
anaesthetics in epidural anaesthesia.7−10 Dexmedetomidine, a 
highly selective α2-adrenoreceptor agonist, has effective 
analgesic and sedative properties11,12 and lacks opioid-related 
side effects.13,14 The effects of a dexmedetomidine–bupivacaine 
mixture in thoracic epidural are mainly studied in patients 
undergoing thoracic surgery with one-lung ventilation in respect 
of the intraoperative awareness and analgesic benefits.15 A study 
comparing the analgesic efficacy of dexmedetomidine with 
fentanyl as an adjunct to ropivacaine in lumbar epidural in 
patients undergoing lower limb orthopaedic procedures under 
regional anaesthesia demonstrated that dexmedetomidine may 
be a better alternative to fentanyl as it provided early onset of 
sensory anaesthesia and prolonged postoperative analgesia.16 In 
this study we compared the postoperative analgesic efficacy of 
bupivacaine with dexmedetomidine against bupivacaine with 
fentanyl administered using patient-controlled epidural 
anaesthesia (PCEA) in patients undergoing upper abdominal 
surgery. The primary outcome of this study was postoperative 
analgesic requirements and pain scores while the secondary 
outcomes were intraoperative analgesic consumption, 
haemodynamic stability and adverse effects.
Methods
After receiving approval from our institutional ethics committee 
and obtaining written informed consent from the patients, this 
prospective, randomized, double-blind controlled trial was 
conducted in 40 adults ASA grade I–II, undergoing elective upper 
abdominal surgery (hepaticojejunostomy/hemicolectomy). The 
trail was registered with the clinical trial registry (registration no 
CTRI/2014/08/004806; 01/08/2014). Patients on beta-blockers or 
antipsychotic drugs, with cardiac conduction defects, renal or 
hepatic dysfunction, morbid obesity, high risk for postoperative 
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nausea and vomiting (history of smoking, motion sickness or 
excessive postoperative vomiting) or any contraindication to 
epidural catheter insertion (local infection, spine deformities 
etc.) were excluded.
Patients were randomly allocated into two groups by computer-
generated random numbers. Group D patients received 50  μg 
dexmedetomidine with 10 ml of 0.125% bupivacaine via thoracic 
epidural catheter after induction of anaesthesia. Postoperatively, 
the patients used PCEA, each 1  ml containing 1  μg of 
dexmedetomidine in 0.125% bupivacaine. Group F patients 
received 50 μg fentanyl in addition to 10 ml 0.125% bupivacaine 
via thoracic epidural catheter during the intraoperative period, 
and the PCEA with each 1  ml containing 1  μg of fentanyl in 
0.125% bupivacaine, postoperatively. The patients as well as the 
anaesthesiologist involved in the perioperative management 
and data collection were blinded to the group assignment.
The patients underwent preoperative anaesthesia assessment 
on the previous evening and were premedicated with alprazolam 
0.5 mg and ranitidine 150 mg orally the evening before and at 
6:00 am on the morning of surgery. Inside the operating theatre 
routine monitors were attached and baseline readings of heart 
rate, non-invasive blood pressure (NIBP) and oxygen saturation 
(SpO2) were taken. A thoracic epidural catheter was inserted at 
the T8–T9 or T9–T10 intervertebral space, with the patient in the 
sitting position with standard aseptic precautions using an 18-G 
Tuohy needle via a midline approach with a loss of resistance 
method. A test dose of 3  ml of 2% lignocaine with 1:200 000 
adrenaline was given.
Anaesthesia was induced with morphine 0.1 mg/kg followed by 
propofol 2–3  mg/kg until loss of verbal response. Muscle 
relaxation was achieved with vecuronium bromide 0.1  mg/kg 
and the patient’s trachea was intubated when train of four (TOF) 
count reached 0. Anaesthesia was maintained by isoflurane with 
60% nitrous oxide in oxygen titrated to maintain a Bispectral 
index (BIS) value of 40–60. Muscle relaxation was maintained 
with top-ups of vecuronium bromide guided by neuromuscular 
monitoring. The lungs were ventilated with positive pressure 
ventilation to maintain end-tidal carbon dioxide (EtCO2) between 
32 and 36 mmHg. The epidural drug was administered according 
to the group allocation immediately after intubation over a 
period of 10 minutes. Patients’ heart rate, electrocardiography 
(ECG), SpO2, BIS, nasopharyngeal temperature and EtCO2 were 
monitored continuously and blood pressure was taken at five-
minute intervals. The data were recorded every 5 minutes for the 
first 30  minutes and then every 15  minutes till completion of 
surgery.
All patients received a continuous infusion of normal saline at 
the rate of 5–8  ml/kg/hour during the intraoperative period. If 
the BIS value was within the targeted range and mean arterial 
pressure (MAP) exceeded baseline by more than 20% for two 
consecutive readings, a 0.5 μg/kg bolus of intravenous fentanyl 
was given. Hypotension (MAP 20% below baseline) was treated 
with normal saline, and if required i.v. ephedrine 5 mg boluses. 
For bradycardia (heart rate of  <  40  bpm) atropine 0.5  mg was 
administered intravenously. Antiemetic prophylaxis was given 
with ondansetron 0.15  mg/kg at the time of closure of the 
surgical wound. At the end of surgery residual neuromuscular 
blockade was reversed with neostigmine sulphate 50 μg/kg and 
glycopyrrolate 10 μg/kg and the endotracheal tube was removed 
when the TOF ratio was  >  90% and BIS  >  80, with the patient 
breathing adequately.
After surgery the patients were transferred to the Post Anesthesia 
Care Unit (PACU) and were monitored for 24 hours by an 
anaesthesia resident blinded to the patients’ group allocation. 
Postoperative analgesia was managed with intramuscular 
diclofenac 75  mg eight-hourly. For rescue analgesia, a PCEA 
pump containing the drug as per the allotted group was 
connected to the patients’ epidural catheter and set to deliver a 
bolus of 3  ml with a lock-out interval of 10  minutes. Patients’ 
heart rate, blood pressure, oxygen saturation and respiratory 
rate were recorded at regular intervals and the pain score and 
sedation level were assessed at 30-minute interval for the first 3 
hours and then at 4, 6, 8, 12 and 24   hours. The assessment of 
pain was done using modified visual analogue scale (VAS, 0–10, 
wherein 0 stands for ‘no pain’ and 10 stands for ‘worst imaginable 
pain’). Level of sedation was assessed using a modified observer’s 
assessment of alertness/sedation (OAA/S) scale with a score of 1 
= asleep/unrousable to 6 = awake/alert.17 The time 0 started at 
the point when the patient’s epidural catheter was connected to 
the PCEA pump. The total amount of rescue drug required during 
24 hours was noted.
All complications such as bradycardia, hypotension, hypoxia 
(SpO2<92) and respiratory depression (respiratory rate < 8) were 
noted and promptly corrected. Other postoperative adverse 
events like nausea, vomiting, pruritus and urinary retention were 
also recorded and treated accordingly. Postoperative nausea and 
vomiting (PONV) was rated on a three-point scale (0 = no PONV, 
1 = mild nausea, 2 = severe nausea or vomiting ≤ 2 occasions, 3 = 
vomiting on 3 or more occasions) and treated by injecting with 
ondansetron 0.15 mg/kg if the scale was ≥ 2. Pruritus was treated 
with iv diphenhydramine 0.2  mg/kg. Patients’ satisfaction with 
the technique was assessed at 24 hours postoperatively on a 
0–10 point scale (0 = unsatisfied, 10 = fully satisfied).
Statistical analysis
Statistical analysis was performed using SPSS® software (version 
22.0, SPSS Inc, Chicago, IL, USA). Normally distributed variables 
were presented as mean and standard deviation (SD) and 
compared using independent Student’s t-test. Fisher’s exact test 
or chi-square test was used for comparisons of categorical 
variables. Non-parametric data were expressed as median and 
interquartile range and compared by chi-square test or Mann–
Whitney U test. The VAS scores and the haemodynamic changes 
were analysed by repeated measures of analysis of variance with 
subsequent comparisons made using Student’s t-test with 
Bonferroni’s post hoc test. A p-value less than 0.05 was considered 
as significant.
Sample size was calculated to detect a 30% reduction in total 
PCEA consumption in the dexmedetomidine group. On the basis 
of previous study, by taking a mean of 15 ml PCEA consumption 
with standard deviation (SD) of 6 ml we required a minimum of 
18 patients in each group to have 80% power with α-value of 
0.05.
Results
The groups were comparable in respect of demographic data 
and ASA physical status (Table 1). There was no statistically 
significant difference among groups with regard to the duration 
of surgery, intraoperative fentanyl requirement, total intravenous 
fluid administration, blood loss and recovery times (Table 2). The 
total consumption of rescue analgesia via PCEA pump was 
significantly less in the dexmedetomidine group as compared 
with the fentanyl group (p = 0.049) (Figure 1). The postoperative 
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pain scores were comparable among groups throughout the 
postoperative period (Figure 2).
The heart rate was statistically lower in the dexmedetomidine 
group as compared with the fentanyl group at any point in time 
(Figure 3). The mean arterial pressures were comparable among 
groups during the intraoperative and the postoperative period 
(Figure 4). None of the patients had bradycardia and only one 
patient in each group had hypotension. Sedation scores were 
comparable in both groups in the postoperative period except at 
30  minutes postoperatively where the sedation scores were 
lower in the dexmedetomidine group as compared with the 
fentanyl group (p < 0.001) (Figure 5). The patients were easily 
rousable and none of them had respiratory depression or 
hypoxia.
One patient in the fentanyl group had pruritus and two patients 
had postoperative vomiting (grade 2) whereas two patients in 
the dexmedetomidine group had mild nausea. No other adverse 
effects were reported in either of the two groups. Patients 
receiving dexmedetomidine were more satisfied with their 
postoperative pain management as compared with the patients 
having epidural fentanyl (satisfaction score, median (IQR), 8 (6–
8), 6 (5–8) in the dexmedetomidine and fentanyl group 
respectively, p < 0.001).
Discussion
In the present study, we found that addition of dexmedetomidine 
to epidural bupivacaine provided effective intraoperative as well 
as postoperative analgesia comparable to fentanyl with greater 
patient satisfaction. There was no significant difference in 
intraoperative fentanyl requirement between the groups. The 
postoperative pain scores were comparable among groups at all 
time intervals during the 24-hour postoperative period with 
lesser requirement for rescue analgesia in the dexmedetomidine 
group. Our results are similar to the previous study by Selim et 
al.,18 which also reported comparable VAS scores in patients 
receiving dexmedetomidine and fentanyl (1  μg/kg each) for 
labour analgesia with greater patient satisfaction in the 
dexmedetomidine group.18
Table 1: Demographic data
Notes: Values are expressed as mean ± SD; *presented as number of patients.
Variables  Group F (n = 20) Group D (n = 20)
Age (years) 39.55 ± 15.46 38.75 ± 12.09
Weight (kg) 54.65 ± 7.56 55.70 ± 8.02
Height (cm) 157.75 ± 7.22 156.10 ± 5.51
Gender (M/F)* 9/11 7/13
ASA status (I/II)* 14/6 14/6
Table 2: Intraoperative data
Notes: Values are expressed as mean ± SD, *presented as number of patients.
Variables  Group F (n = 20) Group D (n = 20) p-value
Duration of surgery 
(min)
178.25 ± 9.182 176.9 ± 8.117 0.178
Total i.v. fluids (ml) 2960 ± 559.27 3015 ± 409.78 0.725
Blood loss (ml) 343.75 ± 74.28 322.5 ± 64.32 0.340

























GROUP F GROUP D
*
Figure 1: Total rescue analgesic requirement in 24 hours (via PCEA pump). 
*Indicates significant difference between the groups (p = 0.049).
Figure 2: Postoperative pain scores (modified VAS) at various time intervals.
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reported significantly decreased consumption of intraoperative 
fentanyl and improved postoperative analgesia in patients 
receiving dexmedetomidine as compared with bupivacaine 
only. Bajwa et al.16 have also shown that dexmedetomidine 
provided superior postoperative analgesia compared with 
Previous studies have shown that intraoperative 
dexmedetomidine promotes postoperative analgesia and 
reduces the requirement for rescue analgesia. Elhakim et al.15 
evaluated the effects of dexmedetomidine administration in 
thoracic epidural in patients undergoing thoracic surgery and 
Figure 3: Intraoperative heart rate at various time intervals. *Indicates significant difference between the groups (p < 0.05).













































Figure 4: Intraoperative mean arterial pressure (MAP) at various time intervals.
Figure 5: Sedation scores at various time intervals. *Indicates significant difference between the groups (p < 0.05).
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Figure 4: Intraoperative mean arterial pressure (MAP) at various time intervals.
Figure 5: Sedation scores at various time intervals. *Indicates significant difference between the groups (p < 0.05).
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fentanyl in patients undergoing orthopaedic procedures under 
regional anaesthesia. The study found less postoperative 
ropivacaine consumption over 24 hours in the dexmedetomidine 
group with comparable VAS scores. However, none of the studies 
have used PCEA dexmedetomidine as rescue analgesia.
The analgesic effect of dexmedetomidine is mediated by its 
action at the brain, brainstem, spinal cord and peripheral 
tissues.19 Dexmedetomidine causes hyperpolarisation of nerve 
tissues by altering transmembrane action potential and ion 
conductance at the brainstem locus ceruleus. In the spinal cord, 
the analgesic effect is related to the activation of the descending 
medullospinal noradrenergic pathway or to the reduction of 
spinal sympathetic outflow at presynaptic ganglionic sites. 
Epidural opioids have their major site of action on pre- and post-
synaptic receptors in the substantia gelatinosa of the dorsal 
horn, producing selective block of nociceptive pathways.
In the present study we noticed a significant decrease in the 
heart rate in both groups as compared with their baseline value, 
whereas heart rate in the dexmedetomidine group was 
significantly lower than the fentanyl group during the 
intraoperative as well as in the postoperative period. However, 
there was no significant fall in blood pressure in either group. 
Bajwa et al.16 also observed a more prominent reduction in heart 
rate in patients receiving epidural dexmedetomidine as 
compared with fentanyl. They also reported significant decreases 
in MAP compared with baseline in both groups of patients that 
may have been caused by their use of 0.75% ropivacaine. 
Dexmedetomidine leads to reductions in heart rate by increasing 
vagal tone and reducing sympathetic drive. Opioids like fentanyl 
maintain cardiovascular homeostasis mainly via action on the 
nucleus solitarius, dorsal nucleus of the vagus, nucleus ambiguus 
and parabrachial nucleus. However, the predominant effect of 
opioids on the heart rate is to produce bradycardia via central 
vagal nucleus stimulation.
We could not find a statistically significant difference in sedation 
scores between the groups except at 30 minutes post-surgery. 
Administration of dexmedetomidine causes the absence of 
inhibitory control over the ventrolateral preoptic nucleus, 
resulting in a state of ‘rousable sedation’. Fentanyl, being an 
opioid, is also expected to have sedative effects. Intraoperative 
use of opioids is a well-known risk factor for postoperative 
nausea and vomiting. In our study only two patients in the 
fentanyl group had vomiting that can be attributed to the use of 
a prophylactic antiemetic and exclusion of high-risk patients for 
PONV.
The limitation of the present study is that we assessed the 
analgesic requirements for the first 24 hours after surgery. Also 
we did not assess the late postoperative complications, length of 
hospital stay and mortality. Further large multicentre studies are 
required to assess the long-term efficacy and safety of 
dexmedetomidine in different patient populations.
We conclude that the addition of dexmedetomidine to 
bupivacaine in thoracic epidural provided effective perioperative 
analgesia comparable to fentanyl without any significant adverse 
effect in patients undergoing upper abdominal surgery. 
Dexmedetomidine significantly reduces the requirement for 
rescue analgesia during the postoperative period and leads to 
more patient satisfaction than fentanyl.
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